Nobel laureate James Watson claims antioxidants in late-stage cancers can promote cancer progression

09 January 2013

Title:Oxidants, antioxidants and the current incurability of high Myc-driven cancers

Authors:Dr James D. Watson, Cold Spring Harbour Laboratory

Journal:Open Biology

Although mortality from many cancers has been steadily falling, particularly those of the blood (i.e., leukemias), epithelial cancers (carcinomas) and effectively all mesenchymal cancers (sarcomas) remain largely incurable. In Open Biology today, Nobel laureate James D. Watson, Ph.D., presents a novel hypothesis regarding the role of oxidants and antioxidants in cancers that are currently incurable, notably in late-stage metastatic cancers. Watson claims that antioxidants in late-stage cancers can promote cancer progression, a theory he counts “among my most important work since the double helix”.

Watson Dr James Watson. Photo Credit: Jacob Forsell, Hagersten, Sweden

At the heart of his thesis are the group of molecules that scientists call reactive oxygen species. ROS play a role in apoptosis, which allows dysfunctional cells which pose a threat to the survival or organisms to kill themselves. Watson calls ROS “a positive force for life”.

However, ROS are also able to irreversibly damage key proteins and nucleic acid molecules [e.g., DNA and RNA]. Thus under normal circumstances, when they’re not needed to curb dysfunctional cells, ROS are constantly being neutralized by anti-oxidative proteins.  In order to aid this neutralization, we are often urged to eat foods rich in antioxidants such as blueberries. Watson claims that in late-stage cancer, as ROS are needed for apoptosis, suppressing them may promote the progression of threatening cells and hence cancer. He writes “blueberries best be eaten because they taste good, not because their consumption will lead to less cancer.”

Watson also proposes that the cell-killing ability of currently used anti-cancer therapies – notably, toxic chemotherapeutic agents such as Taxol as well as radiation treatment – is mainly due to the action of ROS to induce apoptosis, or programmed cell death. If true, this would explain “why cancers that become resistant to chemotherapeutic control become equally resistant to ionizing radiotherapy.” The common feature would be their common dependence upon a ROS-mediated cell-killing mechanism.

Watson again applies his theory to suggest that cancer cells largely driven by mutant proteins such as RAS and MYC are often hardest to get to respond to treatment because of their high levels of ROS-destroying antioxidants.

Given the current methods of treatment and pace of research, Watson concludes that “Unless we can find ways of reducing antioxidant levels, late-stage cancer 10 years from now will be as incurable as it is today.”

Share this page

Latest news

  • To beard or not to beard 16 April 2014 A study published in the journal of the Royal Society Biology Letters has found that when growing facial hair, men might like to inspect the stubble of their peers. The more people with beards, the less attractive they become.
  • Royal Society Fellows respond to UN climate mitigation report 14 April 2014 The latest UN climate report, the Working Group III Summary for Policymakers from the Intergovernmental Panel on Climate Change (IPCC): 'Climate Change 2014: Mitigation of Climate Change' was launched yesterday. Professor John Shepherd FRS and Professor Andrew Watson FRS commented on the report.
  • Irish President visits Royal Society 09 April 2014 As part of his state visit to the UK the Irish President, Michael D. Higgins visited the Royal Society. His visit was a celebration of the scientific links between Ireland and the United Kingdom.

For a full archive please see the news pages.